Top Editors Abruptly Leave Village Voice Will Bourne, who became editor in chief of The Village Voice in November, and Jessica Lustig, the deputy editor since January, are leaving the weekly publication. They met with the staff at 11 a.m. on Thursday and said that Christine Brennan, executive editor of Voice Media Group, had instructed them to lay off or drastically reduce the roles of five employees on the 20-person staff. More
Sears Didn't Move Fast Enough, CEO Says Sears continues to struggle to get a "decent" return on its assets and the retailer didn't move fast enough to cut expenses after the financial crisis, the CEO said at the annual meeting. More
Leap Motion seals deal with HP Leap Motion, a highly accurate device allowing users to control their PCs with gestures, will be embedded into a range of HP laptops. The controller is able accurately to detect the movement of 10 fingers at once, allowing for intricate gesture-based controls. More
Outside the JPMorgan headquarters in Manhattan. Momo Takahashi / Business InsiderInvestment banks are hiring for 2026 summer interns, including Goldman Sachs and JPMorgan. First-round interviews are underway in some cases, Business Insider has learned. Here's how to ace the HireVue screening process and score a competitive Wall Street internship. The annual race for summer investment-banking internships is kicking off across Wall Street.
By BERNARD CONDON, AP Business Writer
NEW YORK (AP) — Right-wing extremists are celebrating Elon Musk’s straight-arm gesture during a speech Monday, although his intention wasn’t totally clear and some hate watchdogs are saying not to read too much into it.
“I just want to say thank you for making it happen,” Musk said during a speech at Capitol One Arena on Monday afternoon, referring to Donald Trump’s victory in the presidential election.
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully have some AI-designed drugs in clinical trials by the end of the year,” the firm’s Nobel Prize-winning CEO Demis Hassabis told a panel at the World Economic Forum in Davos this week.